Cargando...
Inhibition of the Mechanistic Target of Rapamycin (mTOR)–Rapamycin and Beyond
Rapamycin is a Food and Drug Administration (FDA)-approved immunosuppressant and anticancer agent discovered in the soil of Easter Island in the early 1970s. Rapamycin is a potent and selective inhibitor of the mechanistic target of rapamycin (mTOR) protein kinase, which acts as a central integrator...
Guardado en:
| Publicado en: | Cold Spring Harb Perspect Med |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cold Spring Harbor Laboratory Press
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4852795/ https://ncbi.nlm.nih.gov/pubmed/27048303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/cshperspect.a025924 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|